江苏爱朋医疗科技股份有限公司 2024年年度股东会决议公告 本公司及董事会全体成员保证信息披露内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 1、本次股东会无增加、变更、否决议案的情形； 证券代码：300753 证券简称：爱朋医疗 公告编号：2025-022 2、本次股东会未涉及变更前次股东会决议的情形； 3、本次股东会采取现场投票与网络投票相结合的方式召开。 一、会议的召开情况 1、会议召开的时间 （1）现场会议召开时间为：2025年5月13日（星期二）15:00。 （2）网络投票时间为：通过深圳证券交易所交易系统进行网络投票的具体时间 为：2025年5月13日9:15至9:25，9:30至11:30，13:00至15:00；通过深圳证券交易所互 联网投票系统投票的具体时间为：2025年5月13日9:15至15:00。 2、现场会议召开地点：上海市闵行区联航路1188号3号楼公司会议室。 3、会议表决方式：现场表决与网络投票相结合的方式。 4、会议召集人：江苏爱朋医疗科技股份有限公司董事会。 5、会议主持人：董事长王凝宇先生。 6、会议召开的合法、合规性：本次股东会会议召开符合《中 ...

5月13日，截至收盘，人脑工程概念上涨0.47%，板块资金流出59249.63万。上涨个股家数12个，下跌个 股家数11个。 序代码股票名称现价涨跌幅主力资金净额主力资金净占比1300430诚益通18.95.75302.17万8.442603716塞 力医疗11.684.663118.19万9.103300753爱朋医疗24.473.61557.62万2.914002173创新医疗10.273.325248.86 万7.785603610麒盛科技14.52.91-1548.34万-1.376000516国际医学5.292.521743.64万7.347688626翔宇医疗 39.481.46401.76万5.108301293三博脑科44.421.183564.33万6.579300884狄耐克13.420.682150.70万 3.9210300003乐普医疗11.430.62-745.24万-5.2211002925盈趣科技16.590.42562.26万6.8912688709成都华 微34.440.26805.68万4.46 板块跌幅居前的股票包括：*ST声迅（-3.69%）、ST华通（-3.37%） ...

爱朋医疗5月12日在互动平台上回复投资者称，公司与美国上市公司脑再生科技没有关系。 ...

脑机接口概念股午后持续走低，爱朋医疗（300753）跌近10%，均普智能跌超7%，荣泰健康 （603579）跌超6%，诚益通（300430）、三博脑科（301293）、翔宇医疗跟跌。 ...

Core Insights - The medical beauty sector experienced a slight increase of 0.53% on May 8, with a total capital outflow of 224.7 million [1] - A total of 43 stocks in the sector rose, while 21 stocks declined [1] Top Gainers - The top ten gainers in the sector included: - Aipeng Medical: +13.1% - Haochen Medical: +9.85% - Guangyunda: +9.8% - ST Jingfeng: +5.01% - ST Biological: +4.98% - Hangzhou Jiebai: +4.34% - Langzi Co.: +4.11% - Hanyu Pharmaceutical: +2.7% - Xinyaqiang: +1.57% - Dezhan Health: +1.29% [1] Top Losers - The stocks with the largest declines included: - Hanshang Group: -9.99% - Lafang Cosmetics: -6.79% - Changshan Pharmaceutical: -5.7% - ST Suwu: -4.84% - Chaohongji: -4.75% [1]

脑机接口概念股盘初冲高，爱朋医疗（300753）涨超15%，荣泰健康（603579）、麒盛科技（603610） 涨停，南京熊猫（600775）、诚益通（300430）跟涨。 暗盘资金正涌入这些股票，点击速看>>> ...

Market Overview - The Shanghai Composite Index is at 3305.11 points, below the six-month moving average, with a change of 0.80% [1] - The total trading volume of A-shares is 646.819 billion yuan [1] Stocks Breaking Six-Month Moving Average - A total of 272 A-shares have surpassed the six-month moving average today [1] - Notable stocks with significant deviation rates include: - Zhongcheng Technology: 14.42% deviation, with a price increase of 14.99% [1] - Oulutong: 10.01% deviation, with a price increase of 11.78% [1] - Jiusheng Electric: 9.22% deviation, with a price increase of 19.97% [1] Stocks with Smaller Deviation Rates - Stocks that have just crossed the six-month moving average with smaller deviation rates include: - Yongdong Co., Sumeida, and Yuhua Tian, which have just crossed the six-month line [1] Additional Stocks with Notable Performance - Other stocks with notable performance include: - Benlang New Materials: 8.45% deviation, with a price increase of 10.35% [1] - Quanzhu Co.: 8.00% deviation, with a price increase of 9.85% [1] - Chuanrun Co.: 7.95% deviation, with a price increase of 10.03% [1]

A股脑机接口板块盘初上升，爱朋医疗涨超8%，诚益通、荣泰健康翔宇医疗等涨超5%，狄耐克、三博 脑科等跟涨。 ...

Core Insights - Brain-computer interface (BCI) technology enables direct communication between the brain and external devices, revolutionizing human-machine interaction and integrating advanced technologies such as neuroscience, AI, and new materials [2][4] - The global BCI industry is projected to reach $7.63 billion by 2029, indicating significant growth potential [4] - China and the United States are leading in BCI development, with a notable number of companies and products entering clinical stages [6][7] Industry Overview - The BCI industry is characterized by a competitive landscape with active companies in over 40 countries, primarily in the US and China, where the number of companies exceeds 100 [7] - As of early 2024, China holds 55.62% of the global patent technology in BCI, leading all countries [6] - The industry is still in its early stages, with many startups emerging and a significant increase in patent applications and funding events [55] Key Companies - **Qiangnao Technology**: Founded in 2018, it specializes in non-invasive BCI technology and has over 200 core patents, with a goal to help 1 million disabled individuals regain mobility [10][12] - **Brain Tiger Technology**: Established in 2021, it focuses on flexible invasive BCI technology and has made significant breakthroughs in core technologies [13][15] - **Brain Land Technology**: Founded in 2018, it integrates BCI technology with medical big data and AI, holding 147 patents as of April 2025 [20][21] - **Borecon**: Founded in 2021, it has developed high-performance BCI systems and has over 100 patents [24][25] - **Weiling Medical**: Established in 2019, it is focused on BCI technology and has initiated clinical research for implantable BCI systems [28] - **Roulint Technology**: Founded in 2020, it specializes in non-invasive BCI technology for consumer electronics and medical applications, holding 161 patents [33] - **Aipeng Medical**: Established in 2001, it has invested in BCI technology and developed several non-invasive BCI products [36][37] - **Kedou BCI**: Founded in 2016, it focuses on invasive BCI technology and has developed various microelectrodes and related devices [40][41] - **Sanbo Neuroscience**: Established in 2003, it has over 50 patents and is involved in clinical applications of BCI technology for neurological disorders [43] - **Chengyitong**: Founded in 2011, it has developed several non-invasive BCI prototypes and holds 303 patents, covering key areas of BCI technology [46] Technological Insights - BCI technology is categorized into invasive, semi-invasive, and non-invasive types, with a focus on improving accuracy, feedback speed, and safety [50][52] - The majority of BCI product development is currently centered on non-invasive devices due to their higher safety and market acceptance [53] - As of 2024, there are 222 registered medical devices related to BCI in China, with 194 classified as Class II medical devices [53]

二、前10名无限售条件股东持股情况 一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.1400 | 0.0108 | -1396.3 | 0.0096 | | 每股净资产（元） | 5.4 | 5.53 | -2.35 | 5.45 | | 每股公积金(元) | 2.62 | 2.62 | 0 | 2.62 | | 每股未分配利润(元) | 1.37 | 1.57 | -12.74 | 1.50 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 0.65 | 0.88 | -26.14 | 0.94 | | 净利润(亿元) | -0.18 | 0.01 | -1900 | 0.01 | | 净资产收益率(%) | -2.55 | 0.19 | -1442.11 | 0.18 | 数据四舍五入，查看更多财务数据>> | 名称 持有数量(万股) | | 占总股本比例 | 增减情况(万 | ...